secwatch / observer
8-K filed February 10, 2022, 6:59 PM ET ticker COPR CIK 0001263364
M&A confidence high sentiment neutral materiality 0.75

Joway Health changes control: JHP Holdings buys 83% for $100,000; new director appointed

Idaho Copper Corp

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jinghe Zhang

Sole Officer and Director
COPR · Idaho Copper Corp
Effective
2022-02-02
Successor
Ramon Lata
Filed
February 10, 2022, 6:59 PM ET
Jinghe Zhange resigned from his position as sole officer and director of the Company.
Appointed

Ramon Lata

President, Treasurer and Secretary
COPR · Idaho Copper Corp
Effective
2022-02-02
Filed
February 10, 2022, 6:59 PM ET
On February 2, 2022, Mr. Ramon Lata was appointed to the board of the directors upon the resignation of Mr. Zhang. Mr. Lata was also appointed as the President, Treasurer and Secretary of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jinghe Zhang resigned as Sole Officer and Director at Idaho Copper Corp.

Action
resigned
Role
Sole Officer and Director
Exact text from the filing
Jinghe Zhange resigned from his position as sole officer and director of the Company.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Ramon Lata was appointed as President, Treasurer and Secretary at Idaho Copper Corp.

Action
appointed
Role
President, Treasurer and Secretary
Exact text from the filing
On February 2, 2022, Mr. Ramon Lata was appointed to the board of the directors upon the resignation of Mr. Zhang. Mr. Lata was also appointed as the President, Treasurer and Secretary of the Company.
View on SEC.gov

Idaho Copper Corp filing history →

Source: SEC EDGAR
accession 0001213900-22-006483
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.